Yes!! Remember back in 2012 when the stock tanked down to $13, Marty allowed his inner circle to turn in their options issued at $52, then under water, only to reissue new stock options at dramatically lower prices.
That should be illegal!! We the shareholders can not be granted that same opportunity to turn in shares bought in the $50's in 2011 for shares in the teens in 2012. It is not an even playing field! Insiders can't lose given the right to return high priced options for lower ones!!!
Limp, WebMD is now in the quiet period, so they will not be issuing options until the release of 4th qtr. earnings on 2/24/15. As you stated, I do not see the stock moving until they report. Marty continues to control this stock's action so he is able to buy back shares using the previously approved buy back program at these depressed prices. He is the master of financial engineering as he utilizes the fiscal calendar to plot all of his moves for the benefit of insiders first, and shareholders second. He is more than happy to buy back stock from any and all frustrated shareholders.
So far the only options distributed were automatic grants to outside directors under the Company's 2005 Long Term Incentive Plan.
This suggests to me that we shouldn’t expect any serious upward move of the stock before Marty has distributed to his buddies the options they think they are entitled to.
I believe the analysts evaluate each equity based upon their level of disclosure and how it assists them in formulating the financials. WebMD provides limited information between conference calls so I agree with your premise that they are reluctant to stick their necks out.
Perhaps its just that today’s analysts prefer to wait for the guidance of a company before they stick their necks out. So much easier and safer.
Limp, perhaps there will be more "buzz" when the program gets underway and Walgreens and WebMD can measure the level of consumer participation. Also, when Walgreens begins its National TV Advertising and Print /Radio Campaign it may heighten the interest in the analyst community. WebMD has its challenges considering what occurred under Wayne Gattinella and Tony Vuolo back in 2012.
I find it amazing how little interest the partnership between WBMD and WBA is generating.
Given that WBMD is the leading health portal and WBA the largest drug retailing chain in the United States, I would have thought at least some analysts would have sat up und taken notice, not to speak of Wall Street as a whole.
But no – nothing. The silence is deafening…
It appears the early morning volume may have been driven by short covering. As of noon, the stock is up about 2%, which is more consistent with a favorable press release, considering that there were no absolute Revenue and Profit numbers included in the issuance, just a statement about coming in at the high end of the previous guidance.
As I mentioned in a previous post, I thought that if WebMD were to participate in these conferences this January, they may pre-announce earnings so as to avoid direct questions on their performance. Well, that 's exactly what they did. This morning they released a press release stating that the 4th qtr. will come in at the high end of the prior forecast.
yup i sure did,lost a cpl of grand on some call options as i was convinced this would be higher
Tracey, as more and more individuals are actively involved in the execution of a company's strategy and tactical programs, especially those programs involving other corporate entities, then, the greater the chance of a leak.
Back when I was V.P of Marketing, my Administrative Assistant was friends with the President's Administrative Assistant, so when she was issuing memo's from the President, of confidential material, she would tell my Administrator and she would whisper it in my ear. This is how leaks can occur. It could also come from outside suppliers etc.